Cargando…
Humoral factors in ALS patients during disease progression
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting upper and lower motor neurons in the CNS and leading to paralysis and death. There are currently no effective treatments for ALS due to the complexity and heterogeneity of factors involved in motor neuron degene...
Autores principales: | Ehrhart, Jared, Smith, Adam J., Kuzmin-Nichols, Nicole, Zesiewicz, Theresa A., Jahan, Israt, Shytle, R. Douglas, Kim, Seol-Hee, Sanberg, Cyndy D., Vu, Tuan H., Gooch, Clifton L., Sanberg, Paul R., Garbuzova-Davis, Svitlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487852/ https://www.ncbi.nlm.nih.gov/pubmed/26126965 http://dx.doi.org/10.1186/s12974-015-0350-4 |
Ejemplares similares
-
Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2018) -
Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008) -
Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018) -
Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2012) -
Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014)